Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich major pharmaceutical company will announce development of oleic acid-based treatments for bacterial vaginosis by August 2025?
Pfizer • 25%
Johnson & Johnson • 25%
GSK • 25%
Other • 25%
Company press releases and news reports
Oleic Acid Found to Promote Healthy Bacteria Growth, Offers Hope for Recurrent Bacterial Vaginosis Treatment
Aug 19, 2024, 04:37 PM
Researchers have discovered that oleic acid, a naturally occurring fatty acid, can promote the growth of the health-associated vaginal bacterium Lactobacillus crispatus. This finding offers a potential strategy for treating recurrent bacterial vaginosis, a common infection. The study, published in Cell, highlights the metabolic differences in the vaginal microbiome and suggests that oleic acid could be used to restore a healthy vaginal microbiome after infection. The research was conducted by a team at the Broad Institute in collaboration with the Kwon Lab at the Ragon Institute.
View original story
Yes • 50%
No • 50%
Pfizer • 25%
Roche • 25%
GlaxoSmithKline • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Roche • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Merck • 25%
Other • 25%
Pfizer • 25%
AstraZeneca • 25%
Johnson & Johnson • 25%
No partnership • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Alopecia treatment • 25%
Psoriasis treatment • 25%
Eczema treatment • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Roche • 25%
Other • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Sanofi • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Other • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
20-30% • 25%
More than 30% • 25%
0-10% • 25%
10-20% • 25%